Details for Patent: 9,192,608
✉ Email this page to a colleague
Which drugs does patent 9,192,608 protect, and when does it expire?
Patent 9,192,608 protects MORPHINE SULFATE and is included in one NDA.
This patent has ten patent family members in seven countries.
Summary for Patent: 9,192,608
Title: | Morphine formulations |
Abstract: | Provided herein, generally, are pharmaceutical formulations, e.g., injectable pharmaceutical formulations with improved stability, comprising morphine sulfate or a hydrate thereof, and methods of producing and using the same. Also provided herein are kits comprising the formulations, e.g., injectable morphine formulations. |
Inventor(s): | Cuine; Alain (St. Fargeau-Ponthierry, FR), Hoarau; Didier (Claix, FR), Romain; Pauline (Saint Egreve, FR) |
Assignee: | BECTON DICKINSON FRANCE S.A.S. (Le Pont de Claix, FR) |
Application Number: | 14/715,277 |
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 9,192,608
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-001 | Oct 30, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA | ⤷ Try a Trial | ||||
Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-001 | Oct 30, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF PAIN | ⤷ Try a Trial | ||||
Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-002 | Oct 30, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA | ⤷ Try a Trial | ||||
Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-002 | Oct 30, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF PAIN | ⤷ Try a Trial | ||||
Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-003 | Oct 30, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF PAIN | ⤷ Try a Trial | ||||
Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-003 | Oct 30, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,192,608
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2014230834 | ⤷ Try a Trial | |||
Brazil | 112015021586 | ⤷ Try a Trial | |||
Canada | 2902343 | ⤷ Try a Trial | |||
China | 104042565 | ⤷ Try a Trial | |||
China | 109125254 | ⤷ Try a Trial | |||
European Patent Office | 2968132 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |